Elan Corporation, plc (ELN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: david staton	1/3/2005 6:40:32 AM
	Read Replies (1) of 10345

Elan shrs to get boost from MS treatment-Barron's Sun Jan 2, 2005 06:31 PM ET NEW YORK, Jan 2 (Reuters) - Hedge fund manager Larry Feinberg sees shares of Irish drug maker Elan Corp. (ELN.I: Quote, Profile, Research) doubling this year, boosted by a partnership to develop a potentially big drug for multiple sclerosis, according to Barron's online edition. Feinberg said Tysabri has big potential because it is twice as effective as anything now in use and has few side effects, Barron's reported. He expects as many as a quarter of the 180,000 U.S. MS patients on drug therapy to switch to Tysabri by the end of this new year and at least half by the end of 2007, according to Barron's. Feinberg runs Oracle Partners, a fund specializing in health-care companies. yahoo.reuters.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next